F-Star Therapeutics Inc (FSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 21,167 | 11,256 | 28,321 | 0 | 0 |
| Gross Profit | 21,167 | 11,256 | 28,321 | N/A | N/A |
| Operating Expenses | 51,881 | 33,641 | 50,818 | 28,470 | 21,253 |
| Operating Income | -30,714 | -22,385 | -22,497 | -28,470 | -21,253 |
| Interest Expense | 844 | 1,001 | 0 | 0 | 0 |
| Other Income | -97 | -2,234 | -1,253 | 5,616 | -6,426 |
| Pre-tax Income | -31,655 | -25,620 | -23,750 | -22,854 | -27,679 |
| Income Tax | -372 | -1 | -737 | N/A | N/A |
| Net Income Continuous | -31,283 | -25,619 | -23,013 | -22,854 | -27,679 |
| Net Income | $-31,283 | $-25,619 | $-23,013 | $-22,854 | $-27,679 |
| EPS Basic Total Ops | -1.88 | -9.69 | -14.89 | -6.36 | -9.92 |
| EPS Basic Continuous Ops | -1.88 | -9.69 | -14.89 | -6.36 | -9.93 |
| EPS Diluted Total Ops | -1.88 | -9.69 | -14.89 | -7.52 | -9.92 |
| EPS Diluted Continuous Ops | -1.88 | -9.69 | -14.89 | -6.25 | -9.93 |
| EPS Diluted Before Non-Recurring Items | -1.88 | -9.69 | -5.88 | -7.48 | -7.48 |
| EBITDA(a) | $-29,980 | $-21,241 | $-21,653 | $-28,182 | $-21,095 |